Evolocumab Biosimilar, Endotoxin 0.05 EU/mg | C105P.05
Evolocumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade evolocumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype controls are available.
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg | C040P.05
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg | C069P.05
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Brolucizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Aflibercept Biosimilar | C013P
Aflibercept Biosimilar. Zaltrap / Eylea biosimilar CHO stable cell line is available for licensing to manufacture the aflibercept biosimilar protein. The research grade aflibercept biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Omalizumab Biosimilar, N297A Mutant | C020P.NA
Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C020P.LA
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only...
Palivizumab Biosimilar, N297A Mutant | C021P.NA
Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant | C021P.LA
Palivizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use...
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg | C021P.05
Palivizumab Biosimilar, Endotoxin 0.05 EU/mg. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human...
Panitumumab Biosimilar, N297A Mutant | C012P.NA
Panitumumab Biosimilar, N297A Mutant. Panitumab biosimilar CHO stable cell line is available for licensing to manufacture the panitumumab biosimilar protein. The research grade panitumab biosimilar protein is for research use only (RUO). Recombinant human IgG2...